Autohemotherapy, or self-blood therapy, was first described by the French physician Paul Ravaut in 1913 and has been employed in a wide range of chronic disease conditions. Several hundred articles on the subject have been published in mainstream medical journals, such as the Journal of the American Medical Association, mostly from the early 1920s through the early 1940s, as listed in the various Index Medicus volumes (generally under the subject category “serum therapy”).1
Autohemotherapy is not an “alternative therapy”. The reported beneficial action of autohemotherapy has been attributed to the presence of antigens in the blood, which stimulate the production of antibodies when injected into the tissues. This explanation finds support in the work of Dr. E. C. Rosenow (Mayo Foundation, 1915-44), which established the presence of a causative organism or antigen in the blood during active stages of many diseases. Thus the action of autohemotherapy can be compared to that of an autologous vaccine and belongs into the field of immunotherapy.1
The technique is more common in Europe and South America than in the United States. It involves the withdrawal of a small amount of blood (depending on the patient’s condition) from the vein and the reinjection of the same blood back into a muscle or into the vein. The aim of the therapy is to enhance the immune system’s ability to fight disease.
The blood retains its normal components – the usual complement of hormones, antibodies, minerals, and salts. Any metabolic by-products resulting from acute or long-term illnesses also will be present in the blood and their reintroduction into the patient will force the body to mount a fresh immune response to the disease causing substances.
The blood may be mixed with a homeopathic remedy, or ozone (an unstable form of oxygen), before being reinjected into the patient. Dosage and interval depend on the individual patient’s needs.
This technique has been part of the Issels Treatment of immune disorders,
chronic degenerative diseases and cancer.
 Shakman, S. H. Autohemotherapy Reference Manual (Chapter 2). [InstituteOfScience.com/hemo.html] Reprinted with permission.
DISCLAIMER: No claim is made that patients with similar diagnosis and/or treatment/s will respond to the same extent as the patients shown. All testimonials had been provided voluntarily to share their experience with the Issels Treatment and their state of health at the time. Some may have passed away due to age or disease. None of these patients received compensation or are related to the Issels Treatment Centers.